A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 8 (4) , 179-187
- https://doi.org/10.1016/0166-3542(87)90072-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Site of Attachment in Human Rhinovirus 14 for Antiviral Agents That Inhibit UncoatingScience, 1986
- The association of rhinoviruses with lower respiratory tract disease in hospitalized patientsJournal of Medical Virology, 1986
- Prevention and treatment of experimental influenza A virus infection in volunteers with a new antiviral ICI 130,685Journal of Antimicrobial Chemotherapy, 1986
- Synergism between anti-rhinovirus antivirals: Various human interferons and a number of synthetic compoundsAntiviral Research, 1986
- Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adultsAntimicrobial Agents and Chemotherapy, 1986
- Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-InterferonNew England Journal of Medicine, 1986
- Prophylactic Efficacy of Intranasal Alpha2-Interferon against Rhinovirus Infections in the Family SettingNew England Journal of Medicine, 1986
- Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adultsAntimicrobial Agents and Chemotherapy, 1985
- The Common Cold: Control?The Journal of Infectious Diseases, 1984
- Evaluation of the anti-herpesvirus drug combinations: Virazole plus arabinofuranosylhypoxanthine and Virazole plus arabinofuranosyladenineAntiviral Research, 1982